Researchers looked at whether having mystical experiences during esketamine treatment was connected to better outcomes for people with treatment-resistant depression. The study followed 45 patients from two treatment centers who were receiving esketamine, a medication approved for this condition. They measured patients' experiences using a questionnaire during the initial treatment phase.
The main finding was that 58% of patients reported having a mystical experience during treatment. Patients who reported stronger mystical experiences tended to show greater improvement in their depression scores. Interestingly, other effects like dissociation (feeling detached from reality) were not linked to improvement. The study also found that patients who reported higher levels of spirituality before treatment tended to have stronger mystical experiences and better outcomes.
This was an observational study, which means researchers observed what happened without controlling all factors. It shows an association but cannot prove that mystical experiences cause the improvement. The study was small and didn't have a comparison group, so we need larger, more controlled research. For now, this suggests that how patients experience esketamine treatment might be relevant to their recovery, but much more evidence is needed.